Literature DB >> 9445048

The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.

P L Atreya1, M E Peeples, P L Collins.   

Abstract

The NS1 protein (139 amino acids) is one of the two nonstructural proteins of human respiratory syncytial virus (RSV) and is encoded by a very abundant mRNA transcribed from the promoter-proximal RSV gene. The function of NS1 was unknown and was investigated here by using a reconstituted transcription and RNA replication system that involves a minireplicon and viral proteins (N, P, L and M2-1) expressed from separate cotransfected plasmids. Coexpression of the NS1 cDNA strongly inhibited transcription and RNA replication mediated by the RSV polymerase, even when the level of expressed NS1 protein was substantially below that observed in RSV-infected cells. The effect depended on synthesis of NS1 protein rather than NS1 RNA alone. Transcription and both steps of RNA replication, namely, synthesis of the antigenome and the genome, appeared to be equally sensitive to inhibition. The efficiency of encapsidation of the plasmid-derived minigenome was not altered by coexpression of NS1, indicating that the inhibition occurs at a later step. In two different dicistronic minigenomes, transcription of each gene was equally sensitive to inhibition by NS1. This suggested that the gradient of transcriptional polarity was unaffected and that the effect of NS1 instead probably involves an early event such as polymerase entry on the genome. NS1-mediated inhibition of transcription and RNA replication was not affected by coexpression of the M2 mRNA, which has two open reading frames encoding the transcriptional elongation factor M2-1 and the putative negative regulatory factor M2-2. The potent nature of the NS1-mediated inhibition suggests that negative regulation is an authentic function of the NS1 protein, albeit not necessarily the only one.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445048      PMCID: PMC124626     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA.

Authors:  A T Perrotta; M D Been
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

2.  The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA.

Authors:  P R Johnson; P L Collins
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Encapsidation of Sendai virus genome RNAs by purified NP protein during in vitro replication.

Authors:  S C Baker; S A Moyer
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

6.  Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.

Authors:  R Fearns; M E Peeples; P L Collins
Journal:  Virology       Date:  1997-09-15       Impact factor: 3.616

7.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

Authors:  O Elroy-Stein; T R Fuerst; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  46 in total

1.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.

Authors:  A Bermingham; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.

Authors:  K J Lee; I S Novella; M N Teng; M B Oldstone; J C de La Torre
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Domains of human respiratory syncytial virus P protein essential for homodimerization and for binding to N and NS1 protein.

Authors:  U Hengst; P Kiefer
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

4.  RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.

Authors:  T I Cornu; J C de la Torre
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Cells expressing the RING finger Z protein are resistant to arenavirus infection.

Authors:  Tatjana I Cornu; Heinz Feldmann; Juan Carlos de la Torre
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

6.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein.

Authors:  Urs Schneider; Melanie Naegele; Peter Staeheli; Martin Schwemmle
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.